Theravance Biopharma Stock
Your prediction
Theravance Biopharma Stock
The price for the Theravance Biopharma stock decreased slightly today. Compared to yesterday there is a change of -€0.100 (-0.630%).
Pros and Cons of Theravance Biopharma in the next few years
Pros
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
B****
Cons
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Theravance Biopharma vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Theravance Biopharma | -0.630% | -0.633% | -5.988% | 76.404% | - | 52.427% | 9.790% |
| Pacira Pharmaceuticals | -1.820% | 0.000% | 5.882% | 22.034% | - | -39.326% | -54.430% |
| Rockwell Medical Inc. | -6.560% | -4.111% | -15.543% | -68.150% | - | -27.258% | -91.689% |
| Twist Bioscience Corp | -1.940% | -3.726% | 8.262% | -37.429% | -0.718% | 21.994% | -76.164% |
News
Here's Why Shares in Theravance Biopharma Exploded Today
Shares in Theravance Biopharma (NASDAQ: TBPH) surged by more than 21% as of noontime ET today. The move comes as the market digests the previous day's excellent third-quarter results and corporate
Theravance Sales Jump 83 Percent
Theravance Biopharma (NASDAQ:TBPH), a biopharmaceutical company focused on respiratory medicines and rare disease therapeutics, reported its Q2 2025 results on August 12, 2025. The company’s revenue